scholarly journals Epitopes Of Tilapia Red Blood Cells. I. Species-Specific Antibodies For The Control Of Tilapia Breeding Stocks

Author(s):  
Ramy R. Avtalion ◽  
Ziv Machnes ◽  
Ruth Segal ◽  
Andrey Shirak ◽  
Bracha Timan
1957 ◽  
Vol 189 (3) ◽  
pp. 520-526 ◽  
Author(s):  
Bernard N. Halpern ◽  
G. Biozzi ◽  
B. Benacerraf ◽  
C. Stiffel

The clearance rate of nucleated pigeon erythrocytes injected intravenously into mice and rats has been calculated either by routine differential red cell counts or by measuring the radioactivity of the erythrocytes tagged with P32. Histological evidence is given that the foreign erythrocytes are phagocytized by the reticulo-endothelial cells of the liver and spleen. The clearance rate of the foreign erythrocytes, which measures the speed of the phagocytosis, follows in mice a regular exponential function similar to this previously established for other colloids. No spontaneous antibodies to pigeon erythrocytes could be detected in mice. The rapid and complex clearance rate of pigeon erythrocytes observed in rats is related to the existence of spontaneous specific antibodies. The simultaneous injection of pigeon erythrocytes and of India ink into mice, both phagocytized by the RE cells, results in a competition between the two substances in favor of the smaller particles of carbon.


1995 ◽  
Vol 198 (4) ◽  
pp. 877-888 ◽  
Author(s):  
J Soengas ◽  
T Moon

The uptake and metabolism of glucose, alanine and lactate were assessed in red blood cells (RBCs) of the American eel Anguilla rostrata. l-Lactate was metabolized at the highest rates as assessed by O2 consumption and CO2 production, followed by glucose and alanine (rates were approximately half of those observed for lactate). A saturable (Km 10.36±0.60 mmol l-1, Jmax 27.42±2.16 µmol 3-OMG l-1 cell water min-1), sodium-independent but cytochalasin-B-sensitive carrier for d-glucose was observed, which was stereospecific and inhibited by other hexoses. These characteristics are in agreement with those reported for the GLUT-1 glucose carrier of human and Japanese eel erythrocytes. These cells also contained a saturable carrier for l-lactate in the concentration range 0­10 mmol l-1 (Km 6.74±0.36 mmol l-1, Jmax 2.29±0.09 mmol lactate l-1 cell water min-1) whereas, at higher concentrations (10­40 mmol l-1), transport occurred by simple diffusion. The carrier was stereospecific, sodium-independent, fully inhibited by alpha-cyano-4-hydroxycinnamate, DIDS and pyruvate, but less sensitive to SITS, IBCLA and pCMBS. We suggest that this carrier is similar to the H+/monocarboxylate carrier found in mammalian RBCs. Despite the fact that l-alanine transport did not saturate, transport was stereospecific because it was inhibited by d-alanine. These experiments do not, therefore, exclude the existence of an alanine carrier in the eel RBC. The rates of substrate uptake exceeded the ability of the RBC to metabolize the substrate (using 1 mmol l-1 extracellular concentration), with uptake rate/metabolic rate ratios being 2 for alanine, 5 for glucose and 151 for lactate. These experiments indicate that uptake does not limit the ability of the American eel RBC to utilize glucose, alanine or lactate, but that the mechanism(s) of substrate uptake is species-specific.


Blood ◽  
1995 ◽  
Vol 85 (7) ◽  
pp. 1736-1741 ◽  
Author(s):  
VM Novotny ◽  
R van Doorn ◽  
MD Witvliet ◽  
FH Claas ◽  
A Brand

The incidence and consequences of HLA and non-HLA immunization were evaluated in 229 patients with aplastic thrombocytopenia. All patients were transfused with prestorage filtered red blood cells and platelets. On admission, 29 patients presented with HLA antibodies due to prior immunization by pregnancy and/or blood transfusions. Of the 200 patients showing no detectable HLA antibodies on admission, 164 could be evaluated. HLA antibodies developed in 2.7% (3 of 112) of the patients with a negative risk history of prior immunization. The occurrence of HLA antibodies in patients with a history of previous pregnancies or prior non-leukocyte-depleted blood transfusions (risk history positive) was 31% (16 of 52). Of the total of 48 patients who were or became alloimmunized, 92% (44 of 48) had a positive risk history. Ten patients with broad multispecific HLA antibodies with a panel reactivity (PRA) of greater than 70% required transfusions with HLA-matched platelets. Patients with HLA antibodies with lower PRA could be supported by random donor platelets. Two patients developed platelet-specific antibodies, causing transfusion refractoriness that necessitated selecting platelets by the absence of a platelet-specific antigen. Using prestorage leukocyte depletion of red cells and platelets with less than 5 x 10(6) residual leukocytes, 95% of the patients, including patients with a previous risk history or with HLA antibodies with low PRA, can be supported with random donor transfusions for the entire duration of their thrombocytopenic periods.


Surgeries ◽  
2021 ◽  
Vol 2 (1) ◽  
pp. 84-91
Author(s):  
Maximilian Kutschera ◽  
Agnes Pischlaeger ◽  
Larissa Sztulman ◽  
Sibylle Kietaibl ◽  
Andreas Spittler

(1) Background: Cell salvage is highly recommended in orthopedic surgery to avoid allogeneic transfusions. Preparational steps during cell salvage may induce extracellular vesicle (EV) formation with potential thrombogenic activity. The purpose of our study was to assess the appearance of EVs at retransfusion. (2) Methods: After ethics committee approval and informed consent, blood was withdrawn from the autotransfusion system (Xtra, Sorin, Germany) of 23 patients undergoing joint arthroplasty. EVs were assessed by flow cytometry in two times centrifugated samples. EVs were stained with specific antibodies against cellular origins from platelets (CD41), myeloid cells (CD15), monocytes (CD14), and erythrocytes (CD235a). The measured events/µL in the flow cytometer were corrected to the number of EVs in the retransfusate. (3) Results: We measured low event rates of EVs from platelets and myeloid origin (<1 event/µL) and from monocytic origin (<2 events/µL). Mean event rates of 17,042 events/µL (range 12–81,164 events/µL) were found for EVs from red blood cells. (4) Conclusion: Retransfusate contains negligible amounts of potentially thrombogenic EVs from platelet and monocytic origin. Frequent EVs from erythrocytes may indicate red blood cell destruction and/or activation during autologous cell salvage. Further research is needed to investigate the clinical relevance of EVs from salvaged red blood cells.


2016 ◽  
Vol 31 (9) ◽  
pp. 1922-1928 ◽  
Author(s):  
Julia Gleitzmann ◽  
Andrea Raab ◽  
Dirk Schulze ◽  
Hermann Wätzig ◽  
Jörg Feldmann ◽  
...  

Species-specific double and triple isotope dilution mass spectrometry (IDMS) was applied for the precise quantification of Cu,Zn-SOD in human erythrocytes.


Blood ◽  
1955 ◽  
Vol 10 (9) ◽  
pp. 912-925 ◽  
Author(s):  
ELIE P. LEROY ◽  
WILMA SPURRIER

Abstract β-glucuronidase, in concentration above the normal level in the blood, hemolyzed human red blood cells after a latent period of 10 to 12 hours. Erythrocytes sensitized by specific antibodies are lysed in the presence of β-glucuronidase in physiologic concentrations (approximately 200 Fishman units per 100 ml. of serum). Other enzymes, such as hyaluronidase and lysozyme, are hemolytic also. Similarity between these enzymes and the lysins found in pre-incubated tissue extracts is pointed out. It is suggested that β-glucuronidase and hyaluronidase play some role in the destruction of red blood cells under certain pathologic conditions. The inhibition of the lytic action of β-glucuronidase by D-glucosaccharic acid and by small concentration of silver nitrate is shown. Inhibitors of β-glucuronidase lysis could be of some value in the treatment of some hemolytic disorders.


Blood ◽  
2001 ◽  
Vol 97 (2) ◽  
pp. 551-556 ◽  
Author(s):  
Douglas P. Blackall ◽  
Jonathan K. Armstrong ◽  
Herbert J. Meiselman ◽  
Timothy C. Fisher

Abstract This study was designed to assess the binding of glycophorin A–specific antibodies to polyethylene glycol (PEG)-modified red blood cells (RBCs) and evaluate their resistance to invasion byPlasmodium falciparum malaria parasites. RBCs were conjugated with a range of concentrations (0.05 to 7.5 mM) of activated PEG derivatives of either 3.35 or 18.5 kd molecular mass. The binding of glycophorin A–specific antibodies was assessed by hemagglutination and flow cytometry. PEG-modified RBCs were assessed for their ability to form rosettes around Chinese hamster ovary (CHO) cells transiently expressing the glycophorin A binding domain of EBA-175, a P falciparum ligand crucial to RBC invasion. PEG-RBCs were also tested for their ability to be invaded by the malaria parasite. RBCs coated with 3.35 and 18.5 kd PEG demonstrated a dose-dependent inhibition of glycophorin A–specific antibody binding, CHO cell rosetting, and P falciparum invasion. These results indicate that glycophorin A epitopes responsible for antibody and parasite binding are concealed by PEG coating, rendering these cells resistant to P falciparum invasion. These studies confirm the effectiveness of PEG modification for masking RBC-surface glycoproteins. This may provide a means to prevent alloimmunization in the setting of RBC transfusion and suggests a novel method to enhance the effectiveness of exchange transfusion for the treatment of cerebral malaria.


2019 ◽  
Vol 15 (2) ◽  
pp. e1007599 ◽  
Author(s):  
Jasmin Akter ◽  
David S. Khoury ◽  
Rosemary Aogo ◽  
Lianne I. M. Lansink ◽  
Arya SheelaNair ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document